Comments
AstraZeneca's new CEO removes R&D, commercial heads
16.01.2013. | LONDON (Reuters) - AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations in a management revamp designed to speed decision-making....
